©2024 Stanford Medicine
Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers
Not Recruiting
Trial ID: NCT01729689
Purpose
This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in
patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral
therapy may reduce anxiety and improve the well-being and quality of life of patients who
have stage IV non-small cell lung cancer and their caregivers.
Official Title
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
Eligibility
Inclusion Criteria:
- Diagnosis of stage IV non-small cell lung cancer
- At least 6 weeks post-diagnosis
- Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety [HAM-A] >=14)
- Ability to understand and the willingness to sign a written informed consent document
- CAREGIVER: Identified by patient as primary caregiver
- CAREGIVER: At least 14 hours/week spent caring for patient
- CAREGIVER: Current symptoms of anxiety (e.g., HAM-A >= 14)
- CAREGIVER: Ability to understand and the willingness to sign a written informed
consent document
Exclusion Criteria:
- PATIENTS AND CAREGIVERS:
- Active, unstable, untreated serious mental illness
- Other cognitive inability to complete informed consent process or study procedures
Intervention(s):
other: counseling intervention
other: questionnaire administration
procedure: quality-of-life assessment
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061